41493-46-3

Usage

Uses

Used in Pharmaceutical Industry:
[1,2,4]triazolo[4,3-a]quinolin-1(2H)-one is used as a pharmacophore for drug design in the pharmaceutical industry. Its unique structure and potential bioactivity make it a valuable candidate for the development of new drugs with various therapeutic applications.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, [1,2,4]triazolo[4,3-a]quinolin-1(2H)-one is used as a research target to explore its potential biological activities and therapeutic properties. [1,2,4]triazolo[4,3-a]quinolin-1(2H)-one's triazoloquinolinone backbone offers opportunities for the discovery of novel drug candidates with diverse applications in medicine.

Upstream product

• 15793-77-8 2-hydrazinoquinoline 
• 612-62-4 2-Chloroquinoline 
• 4114-31-2 ethylhydrazine carboxylate 
• 103-71-9 phenyl isocyanate 

Relevant academic research and scientific papers

The Base-Promoted Annulation of 2-Hydrazinyl Pyridine and CO2 toward Triazolones

A base-promoted annulation of 2-hydrazinyl pyridine and atmospheric pressure of CO2 has been developed in the presence of silane as reducing reagent, affording a series of triazolones in moderate to excellent yields. CO2 served as a carbonyl source in this transfomation. Moreover, benzamidrazones also worked well under this procedure. Thus, it represents a green, sustainable and straightforward pathway to access triazolone frameworks. (Figure presented.).

NOVEL FUSED TRIAZOLONES AND THE USES THEREOF

This invention relates to novel compounds having the structural diagram (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or prophylaxis of cancer.

Agent for the control of plant-pathogenic organisms

Methods employing and compositions comprising, for the control of plant-pathogenic organisms, specified s-triazolo(4,3-a)quinoline compounds, some of which are claimed as novel compounds.